Augustine M. Manadan

Augustine M. Manadan, MD is a Professor in the Department of Internal Medicine at Rush Medical College, with a focus on rheumatology and autoimmune diseases. He serves as Fellowship Program Director and Program Director for Rush Rheumatology.

• Clinical expertise: Ankylosing spondylitis, Lupus, Rheumatoid arthritis, Sjogren's syndrome, and other inflammatory conditions
• Primary location: Rush Rheumatology - Orthopedic Building (Chicago, IL)

Research Interests span autoimmune/myoinflammatory disorders, infectious disease interactions in rheumatology, and dual antiplatelet therapy risks. His work includes nationwide epidemiological studies on rare conditions like Still's disease and dermatomyositis.

Scientific Contributions include co-authoring the POINT Trial (NCT00991029) on clopidogrel-aspirin combinations post-stroke, revealing conflicting efficacy/safety profiles. His recent 2024 studies examine neuromyelitis optica in lupus/Sjogren's patients and hemophagocytic lymphohistiocytosis in Still's disease.

Publications (>60 total) focus on:

• Antiplatelet therapy complications (2013-2024)
• Autoimmune comorbidities (2006-2024)
• Infectious risks in immunosuppressed patients (2006-2017)
• Readmission patterns in inflammatory myopathies (2023)